Academic Journal
Predictors of recurrence after ablation of atypical atrial flutter: insights from a real-world cohort
| Τίτλος: | Predictors of recurrence after ablation of atypical atrial flutter: insights from a real-world cohort |
|---|---|
| Συγγραφείς: | Azevedo, S, Almeida Carvalho, R, Coutinho Dos Santos, I, Gomes, D, Costa, H, Matos, D, Miguel Rocha Rodrigues, G, Carmo, J, Moscoso Costa, F, Galvao Santos, P, Carmo, P, Cavaco, D, Bello Morgado, F, Adragao, P |
| Πηγή: | Europace ; volume 28, issue Supplement_1 ; ISSN 1099-5129 1532-2092 |
| Στοιχεία εκδότη: | Oxford University Press (OUP) |
| Έτος έκδοσης: | 2026 |
| Περιγραφή: | Background Atypical atrial flutter (AAF) often occurs in patients with advanced atrial remodeling or following atrial fibrillation (AF) ablation, and its management remains challenging. Comparative evidence between pulsed field ablation (PFA) and radiofrequency (RF) energy in this setting is limited. Long-term effectiveness and factors predicting recurrence remain inadequately understood. Methods We retrospectively analyzed 91 consecutive patients who underwent catheter ablation of AAF between January 2023 and September 2025. Baseline variables included age, sex, body mass index (BMI), CHA2DS2-VASc score, left ventricular ejection fraction (LVEF), CT left atrial volume index (LAVi), and prior AF ablation. RF ablation was performed in 56 patients (61%), PFA in 32 (35%), and both modalities in 3 (3%). The primary outcome was recurrence during follow-up, defined as documented AAF or AF on ECG, Holter, or clinical record. Median follow-up was 13 months (IQR 6–21). Predictors of recurrence were assessed using Cox proportional hazards regression. Results Mean age was 70 ± 12 years; 42 (46%) were female. The mean CHA2DS2-VASc score was 3 ± 1, LVEF 53 ± 12%, CT LAVi 61±19ml/m² and BMI 27 ± 4 kg/m². A history of previous AF ablation was present in 42% of patients. Acute procedural success, defined as termination of the clinical atypical flutter during ablation or non-inducibility of any atrial tachycardia at the end of the procedure, was achieved in 77 patients (85%). During follow-up, primary outcome occurred in 27 patients (30%). In multivariate Cox analysis, use of PFA compared with RF (HR 3.29, 95% CI 1.41–7.67, p = 0.006) and higher CHA2DS2-VASc score (HR 1.58, 95% CI 1.15–2.17, p = 0.005) independently predicted recurrence. Conclusions In this contemporary cohort of AAF ablations the primary outcome occurred in approximately one-third of patients. Both the use of PFA and a higher CHA2DS2-VASc score were independently associated with increased recurrence risk. These findings underscore the influence of ... |
| Τύπος εγγράφου: | article in journal/newspaper |
| Γλώσσα: | English |
| DOI: | 10.1093/europace/euag105.954 |
| Διαθεσιμότητα: | https://doi.org/10.1093/europace/euag105.954 https://academic.oup.com/europace/article-pdf/28/Supplement_1/euag105.954/68620016/euag105.954.pdf |
| Rights: | https://creativecommons.org/licenses/by-nc/4.0/ |
| Αριθμός Καταχώρησης: | edsbas.81AA612C |
| Βάση Δεδομένων: | BASE |
καταχωρήστε σχόλιο πρώτοι!